In: PATENT NEWS
He performed post-doctoral research at the German Cancer Research Institute and at the University of California at Berkeley, followed by serving as a group leader at Genentech Inc. where he was exposed to patent-related issues sparking his interest in intellectual property. He earned his law degree …
In: PATENT NEWS
As proof that not all uses of the term “patent troll” are pejorative, Tucker cites a law review article that explains patent trolls play a function as intermediaries specializing in litigation, a role that is not in and of itself a bad thing. So a passage in an article that... Continue reading
In: TRADEMARK NEWS
When Your Trademark Is A False Advertisement Law360 Full coverage
In: PATENT NEWS
The Canadian accounting of profits remedy for patent infringement, which is not available in the United States, provides a potentially significant opportunity for companies with Canadian IP rights. Recent court decisions have highlighted the potential advantages of this remedy. For example, in Dow v …
In: PATENT NEWS
“At this early stage, it is too soon to tell whether these will be precedent-setting cases for patent law generally,” de Beer wrote in a follow-up email. “But they will certainly have a huge impact on the parties, and the industry will be watching closely for implications on other companies’... Continue reading
In: TRADEMARK NEWS
Nepal launches collective tea trademark, HP ramps up anti-counterfeiting efforts, new CITMA president: news round-up World Trademark Review (blog) Full coverage
In: PATENT NEWS
The Supreme Court of the United States hears arguments Monday (April 16) in a patent case that one University of Notre Dame law professor says has major implications for international relations, pitting the U.S. interest in rewarding patent owners for their inventions against the sovereignty of other …
In: COPYRIGHT NEWS
Canadian Music Industry Confirms Once More That For Copyright Companies, Enough Is Never Enough Techdirt Full coverage
In: TRADEMARK NEWS
Poland: Trademark Monitoring In Poland – A Short Assessment After Two Years. Mondaq News Alerts Full coverage
In: PATENT NEWS
Congress, Courts Concurrently Tackle Allergan Patent Scheme Inside Health Policy Full coverage
Designed by Industrial Action
Copyright © 2024 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION